Results 271 to 280 of about 157,285 (342)

Reducing Photo-Oxidative Stress in IVF: A Retrospective Analysis of Cycles with Poor Blastocyst Development. [PDF]

J Clin Med
Gödöny K, Várnagy Á, Mauchart P, Nagy B, Kovács K, Bódis J.   +5 more
europepmc   +1 more source

A model to predict red blood cell transfusion during/after cesarean delivery

Pregnancy, Volume 2, Issue 2, March 2026.
Abstract Background Cesarean delivery is a major risk factor for postpartum hemorrhage. A priority for postpartum hemorrhage safety bundles is the assessment of hemorrhage and transfusion risk following cesarean delivery and the identification of patients at increased risk for postpartum hemorrhage requiring red blood cell transfusion.
Samuel Parry, Steven J. Weiner, George R. Saade, Rebecca G. Clifton, John M. Thorp Jr., Monica Longo, Ashley Salazar, Wendy Dalton, Alan T. N. Tita, Cynthia Gyamfi‐Bannerman, Suneet P. Chauhan, Torri D. Metz, Kara Rood, Dwight J. Rouse, Jennifer L. Bailit, William A. Grobman, Hyagriv N. Simhan, George A. Macones, Luis D. Pacheco, for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal‐Fetal Medicine Units Network   +19 more
wiley   +1 more source

Differences in Maternal and Neonatal Outcomes Between Pregnancies Following Intrauterine Insemination (IUI) and In Vitro Fertilization (IVF): A Review. [PDF]

J Clin Med
Cherouveim P, Cetin E, Tuli S, Lombard T, Youssef Y, Moawad G, Ayoubi JM, Feki A.   +7 more
europepmc   +1 more source

Theological Debate Over Embryo Adoption [PDF]

, 2005
Diamond, Sheila M.
core   +1 more source

Opportunities for renal genetic evaluation among pregnant patients with kidney disease

Pregnancy, Volume 2, Issue 2, March 2026.
Abstract Objective Chronic kidney disease (CKD) can significantly affect pregnancy management and outcomes. Although up to 40% of adults with renal disease have an identifiable genetic cause, most pregnant patients with CKD do not undergo genetic testing, hindering tailored management during and after pregnancy. We assessed which pregnant patients with
Likhita Nandigam, Christian M. Parobek, Taylor Moseley, Ansley E. Davis, Stacie G. Denning, Mir Reza, Sai K. Saridey, Hennie A. Lombaard   +7 more
wiley   +1 more source

Gut microbiota and metabolic dysregulation in polycystic ovary syndrome: effects of acupuncture as an adjunct to <i>in vitro</i> fertilization on gut dysbiosis, metabolism, and oocyte quality. [PDF]

Front Microbiol
Liu JJ, Yang H, Xiao ZY, Xie JH, Su L, Li YT, Zheng XY, Hu WH, Fu SJ, Li CL, Huang L, Yu SY, Yu Z, Yang S, Yang J.   +14 more
europepmc   +1 more source

Twin Pregnancies—Emergency Cerclage in the Second Trimester and Delivery of Second Twins 110 and 123 Days Later

Reproductive, Female and Child Health, Volume 5, Issue 1, March 2026.
ABSTRACT Background: Since the 1980s, the global twinning rate has risen to about 1.6 million twin pairs annually due to the widespread use of IVF. Twin pregnancies carry a higher risk of complications compared to singleton pregnancies, with cervical insufficiency being a significant concern that can lead to preterm birth and adverse perinatal outcomes.
Iakovos Soussis, Efi Roboti, Andreas Bazeos, Sara Sousi, Neratzoula Sakka, Stavros Fotopoulos   +5 more
wiley   +1 more source

Comparative risk of gestational diabetes mellitus following fresh and frozen embryo transfers: a retrospective cohort study in Palestinian women undergoing in vitro fertilization. [PDF]

Diabetol Metab Syndr
Afaneh I, Hussien A, Jabareen M, Abdallah J, Abudaowd S, Fasfoos A, Abbas A, Alhalayqa O, Maraqa B.   +8 more
europepmc   +1 more source

Fetoscopic laser ablation vs standard management for Type‐II and Type‐III vasa previa

Ultrasound in Obstetrics &Gynecology, Volume 67, Issue 3, Page 320-328, March 2026.
ABSTRACT Objective The standard management (SM) for vasa previa (VP) includes antepartum inpatient admission at 28–32 weeks' gestation followed by Cesarean delivery at 34–37 weeks. Case reports and case series have reported on fetoscopic laser ablation (FLA) as an alternative management approach for Types‐II and ‐III VP.
S. Backley, R. H. Chmait, E. P. Bergh, N. Agarwal, A. Llanes, G. Hamadeh, E. Hernandez‐Andrade, A. Johnson, J. Espinoza, A. Salazar, S. Zhu, R. Papanna   +11 more
wiley   +1 more source